Intracerebral Hemorrhage research hub
3 indexed studies · 1 currently recruiting
- active not recruitingPHASE3
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
This study is testing a new treatment for a type of stroke called 'intracerebral haemorrhage' (bleeding in the brain). Doctors want to see if giving a drug called rFVIIa soon after the stroke can reduce bleeding and improve recovery.
United States · Canada · Germany - recruitingPHASE3
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
This study is testing a new treatment called rFVIIa for a serious type of stroke caused by bleeding in the brain. It aims to see if giving this medicine quickly can improve recovery and reduce further bleeding for certain patients.
United States · Canada · Germany - authorisedTherapeutic exploratory (Phase II)
Role of Neuroinflammation and Blood-Brain Barrier Breakdown in Intracerebral Hemorrhage. The INFINITE Study
This study, called INFINITE, looks at how brain inflammation and blood vessel damage might affect recovery after a brain bleed (intracerebral hemorrhage). Researchers use special scans to see these changes and how they link to a person's recovery six months later.
France